InterVivo Solutions Inc., is a responsive and integrated in vivo pre-clinical CRO with the aim of improving the clinical success of new drugs. InterVivo develops and provides translational and predictive animal models and services for establishing proof of concept efficacy, early safety, and pharmacokinetics properties of drug candidates, with a focus on drugs targeting the central nervous system.